Regulation and enzymatic basis of bone resorption by human osteoclasts (Q24293772)

TNF superfamily member 11

GOA release 2020-03-11

1 reference

negative regulation of bone resorption

GOA release 2020-03-11

1 reference

Regulation of the differentiation and function of osteoclasts

GOA release 2020-03-11

author name string

Karen Fuller

series ordinal

1

0 references

Barrie Kirstein

series ordinal

2

0 references

Timothy J Chambers

series ordinal

3

0 references

language of work or name

English

0 references

publication date

June 2007

0 references

published in

Clinical Science

0 references

volume

112

0 references

page(s)

567-75

0 references

issue

11

0 references

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Preparation and characterization of a mouse osteoclast-like multinucleated cell population.

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Quantification of the collagenolytic activity of isolated osteoclasts by enzyme-linked immunosorbent assay.

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Divalent cations mimic the inhibitory effect of extracellular ionised calcium on bone resorption by isolated rat osteoclasts: further evidence for a "calcium receptor"

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures.

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Mechanistic insight into osteoclast differentiation in osteoimmunology

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Characterization of circulating human osteoclast progenitors: development of in vitro resorption assay.

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

'Calcium-activated' intracellular calcium elevation: a novel mechanism of osteoclast regulation.

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Proteinases in bone resorption: obvious and less obvious roles.

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Rapid activation of the medullary bone osteoclast cell surface by parathyroid hormone

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts.

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Bone resorption by osteoclasts

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

The pathobiology of the osteoclast

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Human primary osteoclasts: in vitro generation and applications as pharmacological and clinical assay

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

A novel assay for analysis of the regulation of the function of human osteoclasts

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species production.

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation.

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

The bone lining cell: its role in cleaning Howship's lacunae and initiating bone formation.

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation.

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

Assay for cross-linked carboxyterminal telopeptide of type I collagen (ICTP) unlike CrossLaps assay reflects increased pathological degradation of type I collagen in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021

TGF-beta 1 and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype

1 reference

https://api.crossref.org/works/10.1042%2FCS20060274

7 January 2021